X-group (possible homology)

109 Repetitive alpha hairpins

Ligands and drugs

81,066
Member domains
9,080
with ligand contacts (≤ 4 Å)
11.2% of members
6,623
with DrugDomain annotations
8.2% of members
4,217
with a DrugBank compound
5.2% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

773
Proteins with classified ligands
18
Superclasses bound (of 23)
9.1
Superclasses per 20 proteins
broader than 82% of the 256 X-groups with enough proteins to compare (median 7.6)

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Organic acids and derivatives252117.92.14×q < 0.0001
Organosulfur compounds2615.71.66×q = 0.02
Phenylpropanoids and polyketides2515.91.58×q = 0.05
Homogeneous non-metal compounds204164.01.24×q = 1.4e-3
Benzenoids6055.71.08×q = 0.61
Organic nitrogen compounds2624.31.07×q = 0.75
Organic oxygen compounds151151.80.99×q = 1.00
Lipids and lipid-like molecules6884.90.80×q = 0.09
Homogeneous metal compounds286374.10.76×q < 0.0001
Hydrocarbons45.30.75×q = 0.88
Organoheterocyclic compounds88117.30.75×q = 6.1e-3
Mixed metal/non-metal compounds416.00.25×q = 1.9e-3
Nucleosides, nucleotides, and analogues43210.70.20×q < 0.0001
Organic salts20.82.52×not tested
Miscellaneous inorganic compounds10.61.76×not tested
Organic 1,3-dipolar compounds10.61.57×not tested
Organohalogen compounds22.20.92×not tested
Organometallic compounds11.10.92×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00143GSHGlutathione737
DB00141NAGN-Acetylglucosamine198
DB07780FPPFarnesyl diphosphate83
DB08180MGM2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE74
DB02379BGCBeta-D-Glucose49
DB03003GTSGlutathione sulfonic acid39
DB03310GDSGlutathione disulfide37
DB01780FSCFusicoccin35
DB03686GTBS-(4-nitrobenzyl)glutathione35
DB14128NADNadide32
DB03793BEZBenzoic acid31
DB14981IHPPhytic acid29
DB03345BMEMercaptoethanol28
DB03401I3P1D-myo-inositol 1,4,5-trisphosphate27
DB02458GDNS-(2,4-dinitrophenyl)glutathione23
DB02676B3P2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol23
DB00903EAAEtacrynic acid21
DB04137GTPGuanosine-5'-Triphosphate21
DB01864GSP5'-Guanosine-Diphosphate-Monothiophosphate19
DB00133SERSerine18

Most frequently bound compounds

PDB ligandNameDomains in contact
CAmetalCALCIUM ION1,291
CLCHLORIDE ION915
MGmetalMAGNESIUM ION747
GSHGlutathione677
ZNmetalZINC ION453
Y01CHOLESTEROL HEMISUCCINATE282
NAmetalSODIUM ION249
NAG2-acetamido-2-deoxy-beta-D-glucopyranose227
PSC(7R,17E,20E)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSA-17,20-DIEN-1-AMINIUM 4-OXIDE126
PIO[(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate114
FPPFARNESYL DIPHOSPHATE89
I3PD-MYO-INOSITOL-1,4,5-TRIPHOSPHATE78
POV(2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate76
MGM2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE72
IHPINOSITOL HEXAKISPHOSPHATE69
CLRCHOLESTEROL68
GTXS-HEXYLGLUTATHIONE68
KmetalPOTASSIUM ION59
YBmetalYTTERBIUM (III) ION59
UNXUNKNOWN ATOM OR ION56